Hematologist @massgeneralnews
Massachusetts, USA
Joined June 2016
- Tweets470
- Following220
- Followers922
- Likes2.5K
Rachel Rosovsky retweeted
Superb study published in @CircAHA. First RCT in PE in more than a decade. Big step forward!
Rachel Rosovsky retweeted
@RosovskyRachel Presents STORM-PE RCT Results at VIVA 2025
@PERTConsortium
@roblookstein | @Angiologist
hemostasistoday.com/voices/r…
#Anticoagulation #DeepVenousThrombosis #DVT #Health #Hematology #Hemostasis #STORM_PE #HemostasisToday #Medicine #PERTConsortium #VIVA2025 #PulmonaryEmbolism #Thrombosis #VenousThrombosis #MedEd #MedX
Rachel Rosovsky retweeted
#JustPublished: STORM-PE RCT Primary Outcomes @roblookstein @RosovskyRachel
@sahilparikhmd @angiologist @KNagarshethMD ahajrnls.org/47EvaEU
Thank you @Pertconsortium for partnering with Penumbra on this trial.
Another incredible moment for PE-Storm at #VIVA25! Honored to have partnered with @PenumbraInc on this groundbreaking trial—paving the way for new standards in pulmonary embolism treatment and outcomes. Congratulations @RosovskyRachel @roblookstein
Rachel Rosovsky retweeted
Breaking news! @RosovskyRachel announced the PE- Storm Trial first and secondary results just published.
Thrilled on behalf of all the STORM-PE investigators and patients to share these groundbreaking results. Thank you Circ for simultaneous publication: ahajournals.org/doi/10.1161/…
STORM-PE shows improved functional outcomes for mechanical thrombectomy at discharge and at 90 days @VIVAPhysicians #VIVA25
Thank you Circ for simultaneous publication:ahajournals.org/doi/10.1161/…
Latest Data from Landmark STORM-PE Randomized Controlled Trial Demonstrate that CAVT with Anticoagulation Signific... prn.to/4qYWMOb
Rachel Rosovsky retweeted
Latest Data from Landmark STORM-PE Randomized Controlled Trial Demonstrate that CAVT with Anticoagulation Signific... prn.to/4qYWMOb
Thank you VIVA and honored to present our late breaking abstract, STORM-PE 90 days results showing earlier physiological recovery and improvement in 90 day functional status with MT + AC vs AC alone in intermediate high risk PE pts. Thank you Circ for simultaneous publication. #VIVA2025 @PERTConsortium
#VIVA25: Rachel Rosovsky outlines further results from the STORM-PE RCT with findings simultaneously published in @CircAHA @VIVAPhysicians
Rachel Rosovsky retweeted
#VIVA25: Rachel Rosovsky outlines further results from the STORM-PE RCT with findings simultaneously published in @CircAHA @VIVAPhysicians
Rachel Rosovsky retweeted
Live @TCTConference @crfheart amazing session today discussing the impact of the #STORM-PE data on the future of #PE care. Thank you @PenVascular for the support of the study.
Rachel Rosovsky retweeted
Patients with acute intermediate-high-risk PE who undergo mechanical thrombectomy have a greater reduction in the RV/LV ratio at 48 hours than those treated with anticoagulation alone, according to results from the first-of-its-kind STORM-PE RCT. #TCT2025 tctmd.com/news/mechanical-th…
The first—and only—RCT proving anticoagulation (AC) works for PE was in 1960 with 73 patients. See how far we've come. At #VIVA2025, on behalf of #STORMPE team & in collaboration #PERTConsortium, I’ll present the first RCT comparing MT + AC vs AC alone for acute intermediate–high-risk PE.
@PERTConsortium
@roblookstein
@stavroskonstan7
@IdoWeinberg
@rchannick
@sahilparikhmd
johnmoriarty suhaildohad richarddavis
Rachel Rosovsky retweeted
Live @TCTConference First podium presentation of the #STORM-PE trial!! First RCT of thrombectomy vs Anticoag ever!! Thank you to @crfheart @PenVascular @PERTConsortium for advancing the field
Join us in San Diego for the PERT Consortium 2025 Scientific Symposium. Learn and network with experts from all over the world.
Only 3 days left in the PERT 2025 Registration Summer Sale!
☀️Save $100 on PERT 2025 Registration by using code SUMMER100 (Valid 5/23 - 5/30 only)
Register now: pertconsortium.org/attendee-…
We want to learn from you! How do you evaluate heavy menstrual bleeding in patients on anticoagulation. Take our survey: redcap.link/f8v5m0si
@CardioNerds @isth @ASH_hematology @PERTConsortium @thrombosisday @acweyand @bhwords @aswolberg @fnainle
How do you as a medical provider evaluate heavy menstrual bleeding in patients on anticoagulation? Foundation for Women & Girls w/Blood Disorders is interested in identifying ways to improve care for patients with menorrhagia through research survey. redcap.link/f8v5m0si
How do you as a medical provider evaluate heavy menstrual bleeding in patients on anticoagulation? Foundation for Women & Girls w/Blood Disorders is interested in identifying ways to improve care for patients with menorrhagia through research survey. redcap.link/f8v5m0si
Join us tonight as our Trainee Council members present challenge PE cases from their institutions. Learn from these emerging leaders in the PE space. @FMaeWestMD @jameshorowitzmd @EricSecemskyMD @cardionerds @bhwords @JonnyMoriarty @drandrewsharp @GBarnesMD @klinelabs @DavidACohen3
Future leaders in PE care, don’t miss this! Join us tomorrow for a webinar designed to meet the clinical practice and professional needs of trainees. Hear from emerging and established leaders on the trainee experience, navigating cases, and thriving as a clinician devoted to optimal care for PE patients.
Register now: csavevents.zoom.us/webinar/r…
Excited to present in this important topic with Dr. Bader. Learning Theater 2 at CHEST2024. @PERTConsortium
We are excited to host a special satellite session during #CHEST2024 in Boston, Ma, sponsored by The PERT Consortium™ and supported by Penumbra, Inc.
Escalating Care in Pulmonary Embolism Patients: The Role of Computer Assisted Vacuum Thrombectomy (CAVT)
Register here:chestnet.org/
